atrasentan has been researched along with dinoprost in 3 studies
Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (dinoprost) | Trials (dinoprost) | Recent Studies (post-2010) (dinoprost) |
---|---|---|---|---|---|
358 | 41 | 108 | 11,554 | 940 | 1,936 |
Protein | Taxonomy | atrasentan (IC50) | dinoprost (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.0025 | |
Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.0713 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.14 | |
Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.3 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.14 | |
Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 4.2 | |
Prostaglandin F2-alpha receptor | Bos taurus (cattle) | 0.14 | |
Prostaglandin F2-alpha receptor | Homo sapiens (human) | 0.0139 | |
Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.216 | |
Prostaglandin D2 receptor | Homo sapiens (human) | 4.5 | |
Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.287 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dabbs Loomis, E; Elmarakby, AA; Pollock, DM; Pollock, JS | 1 |
Gariepy, CE; Tykocki, NR; Watts, SW | 1 |
Chen, CC; Hsu, YJ; Lee, TM | 1 |
3 other study(ies) available for atrasentan and dinoprost
Article | Year |
---|---|
ETA receptor blockade attenuates hypertension and decreases reactive oxygen species in ETB receptor-deficient rats.
Topics: Animals; Animals, Genetically Modified; Antihypertensive Agents; Aorta; Atrasentan; Blood Pressure; Dinoprost; Disease Models, Animal; Down-Regulation; Endothelin A Receptor Antagonists; Endothelins; Hypertension; Male; Pyrrolidines; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Sodium Chloride, Dietary; Superoxides; Time Factors | 2004 |
Endothelin ET(B) receptors in arteries and veins: multiple actions in the vein.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Atrasentan; Dinoprost; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelium, Vascular; In Vitro Techniques; Male; Nitroarginine; Oligopeptides; Piperidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Endothelin A; Receptor, Endothelin B; Tunica Intima; Tunica Media; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Venae Cavae; Viper Venoms | 2009 |
Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia.
Topics: Allopurinol; Analysis of Variance; Animals; Antioxidants; Atrasentan; Biomarkers; Cyclic N-Oxides; Dinoprost; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Gout Suppressants; Hypertrophy, Left Ventricular; Hyperuricemia; Isoprostanes; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; RNA, Messenger; Spin Labels; Superoxides; Time Factors; Up-Regulation; Uric Acid; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling; Xanthine Oxidase | 2011 |